Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI
Authors
Keywords
-
Journal
JACC-Cardiovascular Interventions
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-14
DOI
10.1016/j.jcin.2020.12.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization
- (2020) David E. Kandzari et al. JACC-Cardiovascular Interventions
- Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial
- (2019) Azfar Zaman et al. LANCET
- Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction
- (2019) Lorenz Räber et al. EUROPEAN HEART JOURNAL
- Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial
- (2019) Juan F Iglesias et al. LANCET
- Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials
- (2018) Sripal Bangalore et al. CIRCULATION
- A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
- (2018) Robbert J de Winter et al. LANCET
- Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial
- (2018) Thomas Pilgrim et al. LANCET
- Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial
- (2018) Clemens von Birgelen et al. LANCET
- A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial
- (2018) Juan F. Iglesias et al. EuroIntervention
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives
- (2017) Juan F. Iglesias et al. Expert Review of Medical Devices
- Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial
- (2017) David E Kandzari et al. LANCET
- Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention
- (2016) Lisette Okkels Jensen et al. Circulation-Cardiovascular Interventions
- Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial
- (2016) Clemens von Birgelen et al. LANCET
- Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial
- (2016) Manel Sabaté et al. LANCET
- Stent Thrombosis in New-Generation Drug-Eluting Stents in Patients With STEMI Undergoing Primary PCI
- (2014) Giovanna Sarno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial
- (2014) Thomas Pilgrim et al. LANCET
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
- (2011) Kumaran Kolandaivelu et al. CIRCULATION
- Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients
- (2008) Gaku Nakazawa et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search